{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:55:39Z","timestamp":1789390539372,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000697","name":"Rhodes Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000697","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Biotechnology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.copbio.2021.09.012","type":"journal-article","created":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T19:22:00Z","timestamp":1635535320000},"page":"346-354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Virus-like particles against infectious disease and cancer: guidance for the nano-architect"],"prefix":"10.1016","volume":"73","author":[{"given":"Rory A","family":"Hills","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8870-7147","authenticated-orcid":false,"given":"Mark","family":"Howarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.copbio.2021.09.012_bib0005","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.copbio.2021.09.012_bib0010","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.immuni.2020.08.001","article-title":"Multifaceted effects of antigen valency on B cell response composition and differentiation in vivo","volume":"53","author":"Kato","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.copbio.2021.09.012_sbref0015","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/s41565-020-0719-0","article-title":"Role of nanoscale antigen organization on B-cell activation probed using DNA origami","volume":"15","author":"Veneziano","year":"2020","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.copbio.2021.09.012_bib0020","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.3389\/fimmu.2018.01432","article-title":"New routes and opportunities for modular construction of particulate vaccines: stick, click, and glue","volume":"9","author":"Brune","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.copbio.2021.09.012_bib0025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/anie.202009663","article-title":"Overcoming symmetry mismatch in vaccine nanoassembly through spontaneous amidation","volume":"60","author":"Rahikainen","year":"2021","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.copbio.2021.09.012_bib0030","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3390\/pharmaceutics13010098","article-title":"Experimental and computational observations of immunogenic cobalt porphyrin lipid bilayers: nanodomain-enhanced antigen association","volume":"13","author":"Federizon","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.copbio.2021.09.012_bib0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41541-020-0173-x","article-title":"Antibody response of a particle-inducing, liposome vaccine adjuvant admixed with a Pfs230 fragment","volume":"5","author":"Huang","year":"2020","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.copbio.2021.09.012_bib0040","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1038\/s41598-019-40985-w","article-title":"SnoopLigase peptide-peptide conjugation enables modular vaccine assembly","volume":"9","author":"Andersson","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.copbio.2021.09.012_bib0045","article-title":"DogCatcher allows loop-friendly protein-protein ligation","author":"Keeble","year":"2021","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.copbio.2021.09.012_sbref0050","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-13283-2","article-title":"Cytoplasmic glycoengineering enables biosynthesis of nanoscale glycoprotein assemblies","volume":"10","author":"Tytgat","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.copbio.2021.09.012_sbref0055","article-title":"Orthogonal modular biosynthesis of nanoscale conjugate vaccines for vaccination against infection","author":"Li","year":"2021","journal-title":"Nano Res"},{"key":"10.1016\/j.copbio.2021.09.012_sbref0060","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1126\/science.abg2822","article-title":"Evolution of a virus-like architecture and packaging mechanism in a repurposed bacterial protein","volume":"372","author":"Tetter","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.copbio.2021.09.012_sbref0065","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.57659","article-title":"Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens","volume":"9","author":"Ueda","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.copbio.2021.09.012_bib0070","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1021\/acs.biomac.0c00030","article-title":"Virus-like particles (VLPs) as a platform for hierarchical compartmentalization","volume":"21","author":"Waghwani","year":"2020","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.copbio.2021.09.012_bib0075","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1021\/acs.biomac.1c00481","article-title":"Load and display: engineering encapsulin as a modular nanoplatform for protein-cargo encapsulation and protein-ligand decoration using split intein and SpyTag\/SpyCatcher","volume":"22","author":"Choi","year":"2021","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.copbio.2021.09.012_bib0080","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12951-019-0497-8","article-title":"Production and characterization of novel ssRNA bacteriophage virus-like particles from metagenomic sequencing data","volume":"17","author":"Liekni\u0146a","year":"2019","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.copbio.2021.09.012_bib0085","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz8700","article-title":"Increased vaccine tolerability and protection via NF-\u03baB modulation","volume":"6","author":"Moser","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.copbio.2021.09.012_sbref0090","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/vaccines7020047","article-title":"Type of RNA packed in VLPs impacts IgG class switching\u2014implications for an influenza vaccine design","volume":"7","author":"Gomes","year":"2019","journal-title":"Vaccines"},{"key":"10.1016\/j.copbio.2021.09.012_bib0095","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/s41587-019-0390-x","article-title":"Peptide\u2013TLR-7\/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens","volume":"38","author":"Lynn","year":"2020","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.copbio.2021.09.012_bib0100","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nano.2019.01.012","article-title":"Attachment of flagellin enhances the immunostimulatory activity of a hemagglutinin-ferritin nano-cage","volume":"17","author":"Lee","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.copbio.2021.09.012_bib0105","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1158\/2326-6066.CIR-19-0974","article-title":"Virus-like particle\u2013drug conjugates induce protective, long-lasting adaptive antitumor immunity in the absence of specifically targeted tumor antigens","volume":"9","author":"Kines","year":"2021","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.copbio.2021.09.012_bib0110","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.1039\/D0BM01219J","article-title":"The unique potency of Cowpea mosaic virus (CPMV) in situ cancer vaccine","volume":"8","author":"Shukla","year":"2020","journal-title":"Biomater Sci"},{"key":"10.1016\/j.copbio.2021.09.012_bib0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120914","article-title":"Cowpea mosaic virus stimulates antitumor immunity through recognition by multiple MYD88-dependent toll-like receptors","volume":"275","author":"Mao","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.copbio.2021.09.012_bib0120","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202152447","article-title":"Inclusion of cGAMP within virus-like particle vaccines enhances their immunogenicity","volume":"22","author":"Chauveau","year":"2021","journal-title":"EMBO Rep"},{"key":"10.1016\/j.copbio.2021.09.012_sbref0125","article-title":"Active delivery of VLPs promotes anti-tumor activity in a mouse ovarian tumor model","volume":"16","author":"Wang","year":"2020","journal-title":"Small"},{"key":"10.1016\/j.copbio.2021.09.012_bib0130","article-title":"Heterologous arenavirus vector prime-boost overrules self-tolerance for efficient tumor-specific CD8 T cell attack","volume":"2","author":"Bonilla","year":"2021","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.copbio.2021.09.012_sbref0135","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-10192-2","article-title":"The viral protein corona directs viral pathogenesis and amyloid aggregation","volume":"10","author":"Ezzat","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.copbio.2021.09.012_bib0140","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1016\/j.vaccine.2020.03.007","article-title":"Glycoengineered hepatitis B virus-like particles with enhanced immunogenicity","volume":"38","author":"Joe","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.copbio.2021.09.012_sbref0145","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1126\/science.aat9120","article-title":"Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers","volume":"363","author":"Tokatlian","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.copbio.2021.09.012_bib0150","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41565-020-0648-y","article-title":"Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B","volume":"15","author":"Wang","year":"2020","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.copbio.2021.09.012_bib0155","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41590-020-00810-3","article-title":"Intravenous nanoparticle vaccination generates stem-like TCF1+ neoantigen-specific CD8+ T cells","volume":"22","author":"Baharom","year":"2021","journal-title":"Nat Immunol"},{"key":"10.1016\/j.copbio.2021.09.012_bib0160","doi-asserted-by":"crossref","first-page":"12847","DOI":"10.1002\/anie.202013189","article-title":"Structural analysis of an antigen chemically coupled on virus-like particles in vaccine formulation","volume":"60","author":"Jaudzems","year":"2021","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.copbio.2021.09.012_bib0165","doi-asserted-by":"crossref","first-page":"8724","DOI":"10.1021\/acsnano.0c03207","article-title":"Visualization of single molecules building a viral capsid protein lattice through stochastic pathways","volume":"14","author":"Valbuena","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.copbio.2021.09.012_bib0170","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.bpj.2020.09.021","article-title":"Should virus capsids assemble perfectly? Theory and observation of defects","volume":"119","author":"Spiriti","year":"2020","journal-title":"Biophys J"},{"key":"10.1016\/j.copbio.2021.09.012_sbref0175","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-21251-y","article-title":"Complete and cooperative in vitro assembly of computationally designed self-assembling protein nanomaterials","volume":"12","author":"Wargacki","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.copbio.2021.09.012_sbref0180","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.abf6840","article-title":"Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice","volume":"371","author":"Cohen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.copbio.2021.09.012_sbref0185","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41586-021-03365-x","article-title":"Quadrivalent influenza nanoparticle vaccines induce broad protection","volume":"592","author":"Boyoglu-Barnum","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.copbio.2021.09.012_bib0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247963","article-title":"Construction, characterization, and immunization of nanoparticles that display a diverse array of influenza HA trimers","volume":"16","author":"Cohen","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.copbio.2021.09.012_bib0195","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202002140","article-title":"Refocusing the immune response to selected epitopes on a Zika virus protein antigen by nanopatterning","volume":"10","author":"Castro","year":"2021","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.copbio.2021.09.012_bib0200","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41577-021-00578-z","article-title":"Immunological mechanisms of vaccine-induced protection against COVID-19 in humans","volume":"21","author":"Sadarangani","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.copbio.2021.09.012_sbref0205","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1056\/NEJMoa2107659","article-title":"Safety and efficacy of NVX-CoV2373 Covid-19 vaccine","volume":"385","author":"Heath","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.copbio.2021.09.012_bib0210","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-20654-7","article-title":"A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses","volume":"12","author":"Tan","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.copbio.2021.09.012_bib0215","article-title":"A modular protein subunit vaccine candidate produced in yeast confers protection against SARS-CoV-2 in non-human primates","author":"Dalvie","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.copbio.2021.09.012_sbref0220","article-title":"SARS-CoV-2 RBD neutralizing antibody induction is enhanced by particulate vaccination","volume":"32","author":"Huang","year":"2020","journal-title":"Adv Mater"},{"key":"10.1016\/j.copbio.2021.09.012_bib0225","series-title":"A Phase 1\/2 Dose-exploration, Randomized, Observer-blind, Placebo-controlled Study to Determine Safety, Tolerance and Immunogenicity of EuCorVac-19, a Recombinant Protein Vaccine, for the Prevention of COVID-19 in Healthy Adults","author":"EuBiologics Co., Ltd","year":"2021"},{"key":"10.1016\/j.copbio.2021.09.012_bib0230","article-title":"SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity","author":"Joyce","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.copbio.2021.09.012_bib0235","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.cell.2020.10.043","article-title":"Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2","volume":"183","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.copbio.2021.09.012_bib0240","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-20251-8","article-title":"Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity","volume":"12","author":"Fougeroux","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.copbio.2021.09.012_bib0245","article-title":"Interim report of a phase 2 randomized trial of a plant-produced virus-like particle vaccine for Covid-19 in healthy adults aged 18-64 and older adults aged 65 and older","author":"Gobeil","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.copbio.2021.09.012_sbref0250","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/S0140-6736(21)00943-0","article-title":"Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial","volume":"397","author":"Datoo","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.copbio.2021.09.012_bib0255","doi-asserted-by":"crossref","first-page":"46621","DOI":"10.1038\/srep46621","article-title":"Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine","volume":"19","author":"Collins","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.copbio.2021.09.012_bib0260","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.3389\/fimmu.2019.02931","article-title":"A universal plug-and-display vaccine carrier based on HBsAg VLP to maximize effective antibody response","volume":"10","author":"Marini","year":"2019","journal-title":"Front Immunol"}],"container-title":["Current Opinion in Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958166921001890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958166921001890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T09:18:18Z","timestamp":1760692698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0958166921001890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":52,"alternative-id":["S0958166921001890"],"URL":"https:\/\/doi.org\/10.1016\/j.copbio.2021.09.012","relation":{},"ISSN":["0958-1669"],"issn-type":[{"value":"0958-1669","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Virus-like particles against infectious disease and cancer: guidance for the nano-architect","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.copbio.2021.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}